News
Why 2017 Was a Year to Remember for Exact Sciences Corporation
Any year that a stock goes up 40% would count as a memorable year. But what about a year where a stock soars nearly 340%? That's what has happened for Exact Sciences Corporation (NASDAQ: EXAS) in....
Here's Why Sangamo Therapeutics Rose as Much as 14.9% Thursday
Shares of biopharma Sangamo Therapeutics (NASDAQ: SGMO) rose nearly 15% today after the company received favorable coverage in multiple media outlets. Biotech thought leaders STAT Plus and Genetic....
Gilead Sciences Stock Upgraded: This Is the Power of Free
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.
The American Cancer Society expects 600,920 Americans to die from cancer this year, but Ziopharm Oncology Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) aim to lower that....
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Intuitive Surgical, Inc. (NASDAQ: ISRG) shareholders have plenty of reasons to enjoy a happy holiday season. The stock is at an all-time high. Intuitive Surgical is on track to generate $3 billion....
Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE: JNJ) casts a wide net over the sector. The company not only sells well-known consumer brands like Tylenol and....
Are Viruses a Problem for CAR-T Drugmakers?
Chimeric antigen receptor T-cell therapy (CAR-T) could change how doctors treat cancer patients; however, creating these drugs is complicated and a flurry of research and commercialization....
Better Buy: GlaxoSmithKline plc vs. Pfizer
Big drug companies can add an element of stability to investor portfolios. People get sick and need treatment whether the economy is booming or tanking. And big pharma tends to pay hefty....
UnitedHealth Wants to Be the Next Tech Incubator
It appears UnitedHealth Group (NYSE: UNH), the largest health insurer in the U.S., doesn't think the market is moving fast enough to develop new healthcare technology. On Tuesday, the company....
Healthcare Investing Risks and How to Mitigate Them
Healthcare is constantly coming under the fire of political and media attention, and biotech companies are going boom or bust on FDA approvals that are out of their control. But healthcare is also....
What You Need to Know About Systematic Risk
We're a stock-picking company at The Motley Fool, and we tend to sing the praises of investing in individual companies for the long term -- but that's not to say that stock-picking is without its....
Here's How Alnylam Pharmaceuticals, Inc. Crushed It in 2017
After a horrible 2016 following the loss of its lead drug candidate, Alnylam Pharmaceuticals (NASDAQ: ALNY) has had a pretty stellar year, up 238% so far.Much of that increase has come in the last....
Why Ekso Bionics Dropped as Much as 15.8% Wednesday
Shares of exoskeleton suit leader Ekso Bionics (NASDAQ: EKSO) fell nearly 16% Wednesday without any new sales reports. The company did issue a new press release, but it detailed the results of....
Here's Where Things Went Wrong for Celldex Therapeutics, Inc. in 2017
For Celldex Therapeutics (NASDAQ: CLDX), 2016 was a horrible year. The biotech stock dropped 77% after experimental vaccine Rintega flopped in a late-stage clinical study. Celldex entered 2017....
Why 2017 Was a Year to Remember for Illumina, Inc.
Happy days are here again for Illumina, Inc. (NASDAQ: ILMN).Shareholders were accustomed to huge gains for the stock in previous years, but they were sorely disappointed by the gene-sequencing....
3 Top Big Pharma Stocks to Buy Now
Big pharma stocks have been longtime favorites among investors for several reasons. The fact that they're big means that that they generate huge cash flow, which typically translates to attractive....
3 Dividend Stocks With Better Yields Than McDonald's
If you want fast food, McDonald's Corporation (NYSE: MCD) might be a good option. But despite the stock's status as a Dividend Aristocrat, there are better alternatives than McDonald's if you're....
3 Growth Stocks for the Long Term
What investor doesn't like growth? If a stock generates enough growth, dividends and valuation become relatively insignificant. Growth is king.We asked three Motley Fool investors which growth....
Is First Data Corp. a Buy?
First Data Corp. (NYSE: FDC) is a payment-processing company that offers retailers card and mobile payment acceptance capabilities for online and point-of-sale (POS) transactions. First Data is....
Why Aratana Therapeutics Inc. Is Tanking Today
In response to announcing a secondary common stock offering, shares of Aratana Therapeutics (NASDAQ: PETX), a commercial stage biotech focused on pet health, fell 14% as of 11:35 a.m. EST on....
Medicrea acquiert 3 brevets auprès du Dr Paul McAfee et développe la planification chirurgicale des dispositifs intersomatiques titane imprimés en 3D
Medicrea acquiert 3 brevets auprès du Dr Paul McAfee et développe la planification chirurgicale des dispositifs intersomatiques titane imprimés en 3D
Lyon et New York, 28 novembre, 2017 - Le....
Evotec: Schnäppchen oder fallendes Messer?
Evotec ist in diesen Tagen wieder in aller Munde. Der Aktienkurs kommt nicht auf die Beine und nach dem Ausverkauf der letzten Wochen um zeitweise bis zu 46 Prozent auf 12 EUR, wittern viele....
Why Omeros Corporation Is the Best Buy in Biotech Right Now
Omeros Corporation (NASDAQ: OMER) stock soared after the company reported surprisingly good results recently, but there's a lot more fuel in the tank to propel it even higher. This small-cap....
This Small-Cap Biotech Stock Is Onto Something Big
I recently had the pleasure of chatting with Flexion Therapeutics (NASDAQ: FLXN) CEO Mike Clayman about the company's plans for Zilretta, a newly approved medicine treating osteoarthritis of the....
Why Quidel Corporation Is Sinking
After the company announced that it is being sued by one of its customers, shares of Quidel Corporation (NASDAQ: QDEL), a maker of diagnostic testing equipment, fell 10% as of 3:45 p.m. EST on....